JP7134322B2 - ＡＧＥｓ形成抑制用組成物 - Google Patents
ＡＧＥｓ形成抑制用組成物 Download PDFInfo
- Publication number
- JP7134322B2 JP7134322B2 JP2021193220A JP2021193220A JP7134322B2 JP 7134322 B2 JP7134322 B2 JP 7134322B2 JP 2021193220 A JP2021193220 A JP 2021193220A JP 2021193220 A JP2021193220 A JP 2021193220A JP 7134322 B2 JP7134322 B2 JP 7134322B2
- Authority
- JP
- Japan
- Prior art keywords
- celery
- composition
- suppressing
- ages
- rutin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000015572 biosynthetic process Effects 0.000 title claims description 49
- 239000000203 mixture Substances 0.000 title claims description 32
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 65
- 240000007087 Apium graveolens Species 0.000 claims description 64
- 235000010591 Appio Nutrition 0.000 claims description 64
- 239000000284 extract Substances 0.000 claims description 40
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 32
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 32
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 32
- 235000005493 rutin Nutrition 0.000 claims description 32
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 32
- 229960004555 rutoside Drugs 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000003112 inhibitor Substances 0.000 claims description 10
- 230000002401 inhibitory effect Effects 0.000 claims description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 6
- 239000002453 shampoo Substances 0.000 claims description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims 11
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 14
- 230000003779 hair growth Effects 0.000 description 9
- 108010088751 Albumins Proteins 0.000 description 8
- 102000009027 Albumins Human genes 0.000 description 8
- 230000002500 effect on skin Effects 0.000 description 8
- 210000002889 endothelial cell Anatomy 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000036542 oxidative stress Effects 0.000 description 5
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000004761 scalp Anatomy 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000036252 glycation Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000005622 Receptor for Advanced Glycation End Products Human genes 0.000 description 2
- 108010045108 Receptor for Advanced Glycation End Products Proteins 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 230000003813 thin hair Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 244000101724 Apium graveolens Dulce Group Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- -1 contraindications Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 150000003305 rutin Chemical class 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/10—Energy storage using batteries
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021193220A JP7134322B2 (ja) | 2020-05-01 | 2021-11-29 | ＡＧＥｓ形成抑制用組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020081531A JP2021175715A (ja) | 2020-05-01 | 2020-05-01 | ＡＧＥｓ形成抑制用組成物 |
| JP2021193220A JP7134322B2 (ja) | 2020-05-01 | 2021-11-29 | ＡＧＥｓ形成抑制用組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020081531A Division JP2021175715A (ja) | 2020-05-01 | 2020-05-01 | ＡＧＥｓ形成抑制用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022031819A JP2022031819A (ja) | 2022-02-22 |
| JP2022031819A5 JP2022031819A5 (enrdf_load_stackoverflow) | 2022-05-12 |
| JP7134322B2 true JP7134322B2 (ja) | 2022-09-09 |
Family
ID=87888284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021193220A Active JP7134322B2 (ja) | 2020-05-01 | 2021-11-29 | ＡＧＥｓ形成抑制用組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7134322B2 (enrdf_load_stackoverflow) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009096731A (ja) | 2007-10-15 | 2009-05-07 | Kumamoto Univ | カルボキシメチルアルギニン生成抑制剤 |
| JP2016006036A (ja) | 2014-05-26 | 2016-01-14 | アークレイ株式会社 | ＡＧＥｓ分解剤およびその用途 |
| JP2018188375A (ja) | 2017-04-28 | 2018-11-29 | 株式会社アンチエイジングコミュニケーション | ペントシジン生成阻害剤 |
-
2021
- 2021-11-29 JP JP2021193220A patent/JP7134322B2/ja active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009096731A (ja) | 2007-10-15 | 2009-05-07 | Kumamoto Univ | カルボキシメチルアルギニン生成抑制剤 |
| JP2016006036A (ja) | 2014-05-26 | 2016-01-14 | アークレイ株式会社 | ＡＧＥｓ分解剤およびその用途 |
| JP2018188375A (ja) | 2017-04-28 | 2018-11-29 | 株式会社アンチエイジングコミュニケーション | ペントシジン生成阻害剤 |
Non-Patent Citations (4)
| Title |
|---|
| Evidence-Based Complementary and Alternative Medicine，2020年02月19日，Volume 2020, Article ID 8321732，p. 1-12，https://doi.org/10.1155/2020/8321732 |
| Notulae Botanicae Horti Agrobotanici Cluj-Napoca，2017年，45(1)，p. 179-184，DOI:10.15835/nbha45110678 |
| ヘアリプロ史上最多の5種類の有効成分を配合した『へアリプロ 薬用スカルプグロウ JET』4月17日（金）より，2020年04月17日，https://www.aderans.co.jp/newsrelease/detail/20200417124326.html |
| 糖化ストレスと抗糖化作用の評価，オレオサイエンス，2018年，第18巻、第2号，p. 67-73，https://www.jstage.jst.go.jp/article/oleoscience/18/2/18_67/_pdf/-char/ja |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022031819A (ja) | 2022-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3275999B1 (en) | Method for inducing pluripotent stem cells and pluripotent stem cells prepared by said method | |
| JP6697479B2 (ja) | 発毛又は育毛促進用及び抗炎用組成物 | |
| CN104382980A (zh) | 一种具有延缓衰老的星油藤茎叶提取物及其制备和应用 | |
| KR20130135164A (ko) | 에델바이스 추출물을 포함하는 피부 재생 및 모발 성장 촉진제 | |
| CN111544324B (zh) | 一种改善皮肤弹性的组合物及化妆品 | |
| US10617730B2 (en) | Composition for preventing alopecia or stimulating hair growth containing extracellular polysaccharide produced from ceriporia lacerata as active ingredient | |
| CN113577118B (zh) | AGEs形成抑制用组合物 | |
| EP2620492B1 (en) | Platelet-derived growth factor-bb production promoter, and mesenchymal stem cell production promoter, stem cell stabilizer and dermis regenerator each comprising same | |
| JP7134322B2 (ja) | ＡＧＥｓ形成抑制用組成物 | |
| KR20110078361A (ko) | 인삼 열매 추출물을 함유하는 백모 방지용 및 백반증 치료용 조성물 | |
| KR20090104223A (ko) | 항노화용 화장료 조성물 | |
| CN116240259B (zh) | 从人参提取化合物的方法、含有所述化合物的人参提取物及含有其的皮肤屏障强化用组合物 | |
| JP7198275B2 (ja) | 梅の花抽出物を含む微塵による皮膚細胞損傷ケア用組成物 | |
| KR20150105721A (ko) | 구기자나무의 복합추출물을 유효성분으로 함유하는 피부 노화 억제 화장료 조성물 | |
| KR20150031312A (ko) | 배양된 테오브로마 카카오 세포 또는 그의 추출물을 함유하는 피부과용 조성물 및 관련 방법 | |
| JP2021181494A (ja) | 皮脂産生抑制剤 | |
| TWI687237B (zh) | 克魯茲王蓮的萃取物用於提升角蛋白基因及透明質酸合成酶２基因的表現量及提升皮膚的保濕能力之用途 | |
| JP6047793B2 (ja) | 酵素活性阻害剤 | |
| KR101914866B1 (ko) | 가야보리수(Elaeagnus umbellata) 잎 추출물을 유효성분으로 포함하는 콜라게네이즈 또는 MMP-1 발현 억제용 시약 조성물 및 이의 억제 방법 | |
| EP4385489A1 (en) | Hair care composition and banana flower extract and method for hair care using the same | |
| KR102406981B1 (ko) | 항산화 및 항염 활성을 가지는 개구리발톱 추출물을 유효성분으로 함유하는 피부주름 개선용 조성물 | |
| JP7598613B2 (ja) | Ａｔｐ産生促進剤 | |
| JP2012140405A (ja) | ベオミセス酸高含有ムシゴケ抽出物の製造方法 | |
| KR102313083B1 (ko) | 등수국 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 조성물 | |
| JP2024088057A (ja) | １２型コラーゲン産生促進剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220428 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220428 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20220428 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220531 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220725 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220823 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220830 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7134322 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |